August 1, 2026 · Form 4 insider transaction
Gallman Cari bought 1,061 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
These restricted stock units vested in three equal installments beginning on August 1, 2024.